全文获取类型
收费全文 | 220篇 |
免费 | 11篇 |
专业分类
林业 | 5篇 |
农学 | 7篇 |
8篇 | |
综合类 | 40篇 |
农作物 | 3篇 |
水产渔业 | 2篇 |
畜牧兽医 | 161篇 |
园艺 | 2篇 |
植物保护 | 3篇 |
出版年
2023年 | 4篇 |
2020年 | 7篇 |
2019年 | 6篇 |
2018年 | 6篇 |
2017年 | 4篇 |
2016年 | 4篇 |
2015年 | 3篇 |
2014年 | 8篇 |
2013年 | 9篇 |
2012年 | 6篇 |
2011年 | 2篇 |
2010年 | 3篇 |
2009年 | 3篇 |
2008年 | 4篇 |
2007年 | 7篇 |
2006年 | 5篇 |
2005年 | 3篇 |
2004年 | 2篇 |
2003年 | 1篇 |
2002年 | 8篇 |
2001年 | 3篇 |
2000年 | 1篇 |
1999年 | 7篇 |
1998年 | 16篇 |
1997年 | 15篇 |
1996年 | 14篇 |
1995年 | 9篇 |
1994年 | 7篇 |
1993年 | 7篇 |
1992年 | 4篇 |
1991年 | 8篇 |
1990年 | 12篇 |
1989年 | 10篇 |
1988年 | 6篇 |
1987年 | 2篇 |
1986年 | 1篇 |
1985年 | 1篇 |
1984年 | 1篇 |
1983年 | 2篇 |
1981年 | 1篇 |
1980年 | 1篇 |
1979年 | 1篇 |
1975年 | 1篇 |
1973年 | 1篇 |
1972年 | 1篇 |
1968年 | 1篇 |
1945年 | 2篇 |
1931年 | 1篇 |
排序方式: 共有231条查询结果,搜索用时 234 毫秒
21.
22.
23.
24.
25.
26.
Summary Various cardiorespiratory and metabolic indices were assessed during treadmill exercise in Thoroughbred and Standardbred racehorses with T wave changes in 4 or more leads on the electrocardiogram or second-degree atrio-ventricular (AV) block, and in horses that had no abnormalities on clinical examination, resting electrocardiography or upper respiratory tract endoscopy. No significant differences in heart rate, plasma lactate concentration, arterial blood gases, oxygen uptake, run time, peak velocity, or blood and red cell volumes were found between normal horses and horses with T wave changes or second-degree AV block. These results indicate that some electrocardiographic findings that are considered by some clinicians to indicate cardiac dysfunction, may have little effect on exercise capacity. 相似文献
27.
28.
29.
30.
McCann ME Rickes EL Hora DF Cunningham PK Zhang D Brideau C Black WC Hickey GJ 《American journal of veterinary research》2005,66(7):1278-1284
OBJECTIVE: To determine cyclooxygenase (COX)-2 selectivity, pharmacokinetic properties, and in vivo efficacy of firocoxib (ML-1,785,713) in cats. ANIMALS: 5 healthy male and 14 healthy female domestic shorthair cats. PROCEDURE: Selectivity of firocoxib for inhibiting COX-2 was determined by comparing the potency for inhibiting COX-1 with that of COX-2 in feline blood. Pharmacokinetic properties were determined after i.v. (2 mg/kg) and oral (3 mg/kg) administration in male cats. In vivo efficacy was evaluated in female cats with lipopolysaccharide (LPS)-induced pyrexia with administration of firocoxib 1 or 14 hours before LPS challenge. RESULTS: Blood concentrations resulting in 50% inhibition of COX-1 and COX-2 activity in vitro were 75 +/- 2 microM and 0.13 +/- 0.03 microM, respectively, and selectivity for inhibiting COX-2 relative to COX-1 was 58. Firocoxib had moderate to high oral bioavailability (54% to 70%), low plasma clearance (4.7 to 5.8 mL/min/kg), and an elimination half-life of 8.7 to 12.2 hours. Firocoxib at doses from 0.75 to 3 mg/kg was efficacious in attenuating fever when administered to cats 1 or 14 hours before LPS challenge. CONCLUSIONS AND CLINICAL RELEVANCE: Firocoxib is a potent COX-2 inhibitor and is the only selective COX-2 inhibitor described for use in cats to date. It is effective in attenuating febrile responses in cats when administered 14 hours before LPS challenge, suggesting it would be suitable for once-a-day dosing. Because selective COX-2 inhibitors have an improved therapeutic index relative to nonselective nonsteroidal anti-inflammatory drugs in humans, firocoxib has the potential to be a safe, effective anti-inflammatory agent for cats. 相似文献